Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Diabetes mellitus type 2
Vaccine safety and efficacy
AON
Confidence
Clinical skills
Influenza-like illness
Vaccines
Adenoviral vector
Vaccine
Cancer
Vaccine acceptance
Coronavirus
COVID-19
HIV
Awareness
Influenza
Antiviral
Internet
Dose escalation
Innate immunity
EMA
Covidom
Adjuvant
Efficacy
Vaccine hesitancy
Dialysis
Attitude to health
Chronic kidney disease
AIDS
COVID-19 vaccines
Co-morbidities
Misinformation
Care management
Effectiveness
EHealth literacy
Practices
Data sharing
Attitudes
AstraZeneca vaccine
Assay
Vaccine effectiveness
Chemotherapy
Cystic fibrosis
Clinical practice
Antiviral therapy
B-lymphocytes
Vaccination
Digital care
Covid 19
Respiratory syncytial virus
Calcium phosphorus evaluation
Risk factors
Clinical trials
Conjugate pneumococcal vaccine
1790GAHB F
Cost of illness
Delphi study
Drug
Immunogenicity
Conditional marketing authorization
DMD
Immunocompromised
Epidemiology
Attitudes of health personnel
Adverse effects
Coadministration
Cohort study
Healthcare workers
Digital health intervention
Antiviral agents
Determinants
HPV vaccine
ANTIRETROVIRAL THERAPY
Determinant
Déterminants
Clinical research
Sleep
Deletion
Boys
Cohort
Catch-up
SARS-CoV-2
Antiretroviral therapy
C-type lectin receptor
COCONEL cohort surveys
Incidence
Hesitancy
Booster response
Elderly
Adults
CERVICOVAGINAL SECRETIONS
Dendritic cells
Alpha variant
Attitude
Disinformation
Covid-19
Acute kidney injury
Immunization
Biomarkers
France